These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 1721492)
1. The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments. Crowe A; Ksiezak-Reding H; Liu WK; Dickson DW; Yen SH Am J Pathol; 1991 Dec; 139(6):1463-70. PubMed ID: 1721492 [TBL] [Abstract][Full Text] [Related]
2. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Bramblett GT; Trojanowski JQ; Lee VM Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer disease proteins (A68) share epitopes with tau but show distinct biochemical properties. Ksiezak-Reding H; Binder LI; Yen SH J Neurosci Res; 1990 Mar; 25(3):420-30. PubMed ID: 1691309 [TBL] [Abstract][Full Text] [Related]
4. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease. Brion JP; Couck AM; Robertson J; Loviny TL; Anderton BH J Neurochem; 1993 Apr; 60(4):1372-82. PubMed ID: 7681101 [TBL] [Abstract][Full Text] [Related]
5. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Goedert M; Jakes R; Crowther RA; Cohen P; Vanmechelen E; Vandermeeren M; Cras P Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):871-7. PubMed ID: 7519852 [TBL] [Abstract][Full Text] [Related]
6. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites. Hoffmann R; Lee VM; Leight S; Varga I; Otvos L Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960 [TBL] [Abstract][Full Text] [Related]
7. First insert of tau protein is present in all stages of tau pathology in Alzheimer's disease. Soltys K; Rolkova G; Vechterova L; Filipcik P; Zilka N; Kontsekova E; Novak M Neuroreport; 2005 Oct; 16(15):1677-81. PubMed ID: 16189476 [TBL] [Abstract][Full Text] [Related]
8. Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains. Tomidokoro Y; Ishiguro K; Igeta Y; Matsubara E; Kanai M; Shizuka M; Kawarabayashi T; Harigaya Y; Kawakatsu S; Ii K; Ikeda M; St George-Hyslop PH; Hirai S; Okamoto K; Shoji M Biochem Biophys Res Commun; 1999 Mar; 256(3):512-8. PubMed ID: 10080929 [TBL] [Abstract][Full Text] [Related]
9. DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope. Vechterova L; Kontsekova E; Zilka N; Ferencik M; Ravid R; Novak M Neuroreport; 2003 Jan; 14(1):87-91. PubMed ID: 12544837 [TBL] [Abstract][Full Text] [Related]
10. Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau. Farías G; González-Billault C; Maccioni RB Mol Cell Biochem; 1997 Mar; 168(1-2):59-66. PubMed ID: 9062894 [TBL] [Abstract][Full Text] [Related]
11. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. Jicha GA; Bowser R; Kazam IG; Davies P J Neurosci Res; 1997 Apr; 48(2):128-32. PubMed ID: 9130141 [TBL] [Abstract][Full Text] [Related]
12. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease. Endoh R; Ogawara M; Iwatsubo T; Nakano I; Mori H Brain Res; 1993 Jan; 601(1-2):164-72. PubMed ID: 8431763 [TBL] [Abstract][Full Text] [Related]
13. A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. Brion JP; Hanger DP; Couck AM; Anderton BH Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):831-6. PubMed ID: 1953678 [TBL] [Abstract][Full Text] [Related]
14. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies. Combs B; Hamel C; Kanaan NM Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838 [TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of an antibody to a beta/A4 sequence with Alzheimer paired helical filaments and tau protein. Caputo CB; Scott CW; Brunner WF Alzheimer Dis Assoc Disord; 1992; 6(4):225-35. PubMed ID: 1363270 [TBL] [Abstract][Full Text] [Related]
16. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202 [TBL] [Abstract][Full Text] [Related]
17. Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain. Al-Hilaly YK; Foster BE; Biasetti L; Lutter L; Pollack SJ; Rickard JE; Storey JMD; Harrington CR; Xue WF; Wischik CM; Serpell LC FEBS Lett; 2020 Mar; 594(5):944-950. PubMed ID: 31721178 [TBL] [Abstract][Full Text] [Related]
18. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. Jicha GA; Lane E; Vincent I; Otvos L; Hoffmann R; Davies P J Neurochem; 1997 Nov; 69(5):2087-95. PubMed ID: 9349554 [TBL] [Abstract][Full Text] [Related]
19. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. von Bergen M; Barghorn S; Müller SA; Pickhardt M; Biernat J; Mandelkow EM; Davies P; Aebi U; Mandelkow E Biochemistry; 2006 May; 45(20):6446-57. PubMed ID: 16700555 [TBL] [Abstract][Full Text] [Related]
20. Characterization of antisera to paired helical filaments and tau. Implication for the extent of tau tightly bound to paired helical filaments. Ihara Y; Kondo J; Miura R; Nakagawa Y; Mori H; Honda T Gerontology; 1990; 36 Suppl 1():15-24. PubMed ID: 1696559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]